Drug details

Orapred ODT (prednisolone sodium phosphate)

type of Corticosteroids

Orapred ODT (prednisolone sodium phosphate) Orally Disintegrating Tablets is indicated in the treatment of the following disease or conditions: allergic, dermatologic diseases, endocrine, gastrointestinal diseases, hematologic diseases, neoplastic, nervous system, ophthalmic conditions, conditions related to organ transplantation, pulmonary diseases, renal, rheumatologic, and specific infectious diseases. Orapred ODT is available as a generic.

This drug may have the following side effects:

• nausea,
• stomach pain,
• dizziness,
• headache,
• slow wound healing,
• mood changes,
• sleep problems (insomnia),
• spinning sensation,
• dry skin,
• increased sweating,
• acne,
• thinning skin,
• bruising or discoloration,

The following drugs are related to Orapred ODT, either as a replacement or used together:

• Hismanal (astemizole (withdrawn from us market))
• Auvi-Q (epinephrine injection)
• Qvar (beclomethasone dipropionate hfa)
• Benadryl (diphenhydramine)
• Benadryl Injection (diphenhydramine injection)
• Tecfidera (dimethyl fumarate delayed release capsules)
• Elidel (pimecrolimus cream)
• Ultravate Cream (halobetasol propionate)
• Millipred (prednisolone tablets)
• Opzelura (ruxolitinib cream)